Your browser doesn't support javascript.
loading
Emerging importance of multidrug-resistant Stenotrophomonas maltophilia infections in neonatal intensive care unit in a tertiary center in Turkey.
Demirbuga, Asuman; Akgün Karapinar, Deniz Bahar; Yasa, Beril; Çoban, Asuman; Öngen, Betigül; Dede, Elif; Mete Atasever, Neslihan; Somer, Ayper; Hançerli Törün, Selda.
Afiliación
  • Demirbuga A; Istanbul University, Istanbul Faculty of Medicine, Departmenf of Pediatrics, Division of Pediatric Infectious Diseases, Istanbul, Turkey. Electronic address: asumandemirbuga@hotmail.com.
  • Akgün Karapinar DB; Istanbul University, Istanbul Faculty of Medicine, Departmant of Medical Microbiology, Istanbul, Turkey.
  • Yasa B; Istanbul University, Istanbul Faculty of Medicine, Department of Neonatology, Istanbul, Turkey.
  • Çoban A; Istanbul University, Istanbul Faculty of Medicine, Department of Neonatology, Istanbul, Turkey.
  • Öngen B; Istanbul University, Istanbul Faculty of Medicine, Departmant of Medical Microbiology, Istanbul, Turkey.
  • Dede E; Istanbul University, Istanbul Faculty of Medicine, Departmenf of Pediatrics, Division of Pediatric Infectious Diseases, Istanbul, Turkey.
  • Mete Atasever N; Istanbul University, Istanbul Faculty of Medicine, Departmenf of Pediatrics, Division of Pediatric Infectious Diseases, Istanbul, Turkey.
  • Somer A; Istanbul University, Istanbul Faculty of Medicine, Departmenf of Pediatrics, Division of Pediatric Infectious Diseases, Istanbul, Turkey.
  • Hançerli Törün S; Istanbul University, Istanbul Faculty of Medicine, Departmenf of Pediatrics, Division of Pediatric Infectious Diseases, Istanbul, Turkey.
Pediatr Neonatol ; 65(2): 183-187, 2024 Mar.
Article en En | MEDLINE | ID: mdl-37919104
OBJECTIVE: Stenotrophomonas maltophilia is an emerging multi-drug resistant, opportunistic pathogen in the neonatal intensive care unit (NICU). In this study, we aimed to assess the incidence, clinical features, antibiotic susceptibility, and treatment options of S. maltophilia infection among the healthcare-associated infections (HAIs) in the neonatal unit. METHODS: In this study, the patients who were hospitalized in the NICU between January 2020 and December 2021 with S. maltophilia isolated from clinical samples were included. Demographic, clinic features, and microbiological findings of the patients were retrospectively evaluated by using the medical records. The samples (lower respiratory tract, urine, peritoneal fluid) were first examined microscopically by gram preparation and cultured. Antibiotic susceptibility tests were performed according to the recommendations of The European Committee on Antimicrobial Susceptibility Testing (EUCAST) for TMP-SMX. RESULTS: S. maltophilia was isolated in 38 clinical samples of the 20 patients who were hospitalized at the NICU between January 2020 and December 2021. A total of 40 % (n = 8) of samples from different patients were accepted as colonization. Ventilator-associated pneumonia was determined in 55 % (n = 11), and urinary tract infection in 5 % (n = 1). S. maltophilia-associated bacteremia was not detected in any of the cases. The TMP-SMX susceptibilities of the strains were as it follows: 3 (15 %) were resistant (R), 7 (28 %) were susceptible (S), and 10 (47 %) were susceptible-increased exposure (I). Three of these patients were given dual antibiotics therapy (levofloxacin plus TMP-SMX) and nine of them were given only TMP-SMX. The most common hospital-acquired infectious agents are Gram negative microorganisms (51 %), followed by coagulase negative staphylococci (CNS), Staphylococcus aureus (24 %) and S. maltophilia (24 %). CONCLUSION: Increasing TMP-SMX resistance and specific drug and dosage-related problems in the neonatal unit are important problems in treatment management.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Combinación Trimetoprim y Sulfametoxazol / Stenotrophomonas maltophilia Límite: Humans / Newborn País/Región como asunto: Asia Idioma: En Revista: Pediatr Neonatol Año: 2024 Tipo del documento: Article Pais de publicación: Singapur

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Combinación Trimetoprim y Sulfametoxazol / Stenotrophomonas maltophilia Límite: Humans / Newborn País/Región como asunto: Asia Idioma: En Revista: Pediatr Neonatol Año: 2024 Tipo del documento: Article Pais de publicación: Singapur